Zinc / RadioS Cancer Research Results

Z, Zinc: Click to Expand ⟱
Features:

Zinc (Zn²⁺) — essential trace element; structural/catalytic cofactor for >300 enzymes and ~10% of the human proteome (zinc-finger transcription factors). Obtained from diet/supplements (e.g., zinc gluconate, acetate, sulfate).

Primary mechanisms (conceptual rank):
1) Metalloprotein cofactor / transcriptional regulation (zinc-finger domains; p53 structural integrity)
2) Redox buffering & signaling modulation (indirect antioxidant; NADPH oxidase/SOD context)
3) Immune regulation (T-cell function; cytokine tone)
4) Apoptosis / mitochondrial signaling (dose-dependent)
5) Synaptic neuromodulation (brain Zn²⁺ pools; excitability)

Bioavailability / PK relevance: Tight homeostatic control (ZIP/ZnT transporters; metallothioneins). Oral absorption varies with form and dietary phytates; systemic free Zn²⁺ remains low (nanomolar). Many in-vitro cytotoxic effects use supra-physiologic micromolar levels.

In-vitro vs oral exposure: Direct tumor cytotoxicity typically at high concentrations (qualifier: high concentration only). Physiologic supplementation mainly corrects deficiency.

Clinical evidence status: Established for deficiency and immune support; oncology data mixed/observational; no stand-alone anti-cancer approval.

Zinc is an essential mineral that supports immune function, wound healing, skin health, and more.

Zinc is an essential cofactor for many enzymes, including superoxide dismutase (SOD), which scavenges free radicals and limits oxidative stress—a known contributor to DNA damage and cancer initiation.

Maintaining adequate zinc status (typically, serum concentrations within a normal reference range of roughly 70–120 µg/dL) is important for overall health, while both deficiency and excessive intake may have implications for cancer risk.

Some zinc-dependent enzymes, such as histone deacetylases (HDACs) or components of chromatin remodeling complexes, rely on zinc for their function.

Zinc can modulate several intracellular signaling cascades. For example, zinc ions may affect the activity of protein kinases and phosphatases.

Evidence suggests that alterations in zinc levels can impact growth factor signaling pathways, which are vital in controlling cell growth and survival and are often dysregulated in cancer.

Zinc is involved in the regulation of cell cycle progression and apoptosis (programmed cell death). It can modulate the activity of several transcription factors (e.g., p53) that regulate growth arrest and apoptosis in response to cellular stress.

Zinc (Zn²⁺) — Cancer vs Normal Cell Pathway Map

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 p53 structural integrity (zinc-finger stabilization) ↑ (if WT p53; context-dependent) ↑ R/G Tumor suppressor function support Zinc required for proper p53 conformation; deficiency impairs DNA damage response.
2 ROS ↓ (physiologic); ↑ (high concentration only) ↓ P/R Redox modulation Indirect antioxidant via metallothionein/SOD; excess Zn²⁺ can induce oxidative stress.
3 NRF2 axis ↑ (mild; context-dependent) ↑ R/G Stress-response activation Zinc can induce metallothionein and antioxidant gene expression.
4 Apoptosis (mitochondrial; caspases) ↑ or ↓ (dose-dependent) ↔ / ↑ (excess) R/G Cell death modulation Low physiologic levels protective; high intracellular Zn²⁺ may trigger apoptosis.
5 Immune signaling (NF-κB; cytokines) ↓ inflammatory tone (indirect) ↓ (balanced immune support) R/G Immune modulation Deficiency elevates inflammation; repletion normalizes cytokine signaling.
6 PI3K/AKT ↔ / ↑ (context-dependent) ↔ R/G Growth signaling influence Zinc transporters (ZIP4, ZIP6) implicated in tumor progression; effect is transporter-context specific.
7 HIF-1α ↓ (some models) ↔ G Hypoxia signaling modulation Reported inhibitory interaction in certain tumor models.
8 Ferroptosis ↔ (limited evidence) ↔ R/G Not primary axis Indirect influence via redox state possible but not canonical driver.
9 Ca²⁺ signaling ↔ / competitive modulation ↔ P/R Ion channel interaction Zinc can modulate NMDA and other channels; more relevant in neurons than oncology.
10 Clinical Translation Constraint ↓ (constraint) ↓ (constraint) — Tight homeostasis Systemic Zn²⁺ tightly regulated; excess supplementation may cause copper deficiency and immune imbalance.

TSF legend:
P: 0–30 min (ion-channel/redox interactions)
R: 30 min–3 hr (signaling modulation)
G: >3 hr (gene-regulatory/phenotype outcomes)


AD relevance: Zinc plays a dual role in Alzheimer’s disease: essential for synaptic function and antioxidant defense, but dysregulated Zn²⁺ can promote amyloid aggregation and excitotoxic injury.

Primary mechanisms (conceptual rank):
1) Aβ aggregation modulation (Zn²⁺ binding to amyloid)
2) Synaptic Zn²⁺ signaling (NMDA modulation; plasticity)
3) Redox buffering (metallothionein induction)
4) Neuroinflammation modulation
5) Tau phosphorylation influence (indirect)

Clinical evidence status: Mixed; deficiency harmful, excess potentially detrimental. No consensus that supplementation benefits established AD unless deficient.

Zinc (Zn²⁺) — AD / Neurodegeneration Pathway Map

Rank Pathway / Axis Cells TSF Primary Effect Notes / Interpretation
1 Aβ aggregation ↑ (excess); ↔ (physiologic) G Plaque stabilization potential Zinc binds Aβ; high synaptic Zn²⁺ may promote aggregation.
2 Synaptic transmission (NMDA modulation) ↔ / modulated P/R Plasticity regulation Vesicular Zn²⁺ co-released with glutamate; influences excitability.
3 ROS ↓ (physiologic); ↑ (excess) P/R Redox balance Deficiency increases oxidative stress; overload promotes injury.
4 NRF2 / Metallothionein ↑ (adaptive) R/G Antioxidant defense Metallothioneins buffer Zn²⁺ and reduce oxidative damage.
5 Neuroinflammation ↔ / ↓ (deficiency correction) R/G Immune balance Optimal zinc supports immune regulation; imbalance may exacerbate inflammation.
6 Ca²⁺ excitotoxicity interplay ↔ / ↑ (excess) P/R Excitotoxic vulnerability High Zn²⁺ can enter neurons and impair mitochondrial function.
7 Clinical Translation Constraint ↓ (constraint) — Homeostatic narrow range Both deficiency and excess harmful; supplementation appropriate only if low.

TSF legend:
P: 0–30 min (synaptic ion effects)
R: 30 min–3 hr (signaling adaptation)
G: >3 hr (aggregation and phenotype changes)
RadioS, RadioSensitizer: Click to Expand ⟱
Source:
Type:
A radiosensitizer is an agent that makes cancer cells more sensitive to the damaging effects of radiation therapy. By using a radiosensitizer, clinicians aim to enhance the effectiveness of radiation treatment by either increasing the damage incurred by tumor cells or by interfering with the cancer cells’ repair mechanisms. This can potentially allow for lower doses of radiation, reduced side effects, or improved treatment outcomes.
Pathways that help Radiosensitivity: downregulating HIF-1α, increase SIRT1, Txr

List of Natural Products with radiosensitizing properties:
-Curcumin:modulate NF-κB, STAT3 and has been shown in preclinical studies to enhance the effects of radiation by inhibiting cell survival pathways.
-Resveratrol:
-EGCG:
-Quercetin:
-Genistein:
-Parthenolide:

How radiosensitizers inhibit the thioredoxin (Trx) system in cellular contexts. Notable radiosensitizers, including:
-gold nanoparticles (GNPs),
-gold triethylphosphine cyanide ([Au(SCN) (PEt3)]),
-auranofin, ceria nanoparticles (CONPs),
-curcumin and its derivatives,
-piperlongamide,
-indolequinone derivatives,
-micheliolide,
-motexafin gadolinium, and
-ethane selenide selenidazole derivatives (SeDs)
Scientific Papers found: Click to Expand⟱
5749- CA,  Z,  Rad,    Antitumor and Radiosensitizing Effects of Zinc Oxide-Caffeic Acid Nanoparticles against Solid Ehrlich Carcinoma in Female Mice
- vitro+vivo, BC, MCF-7 - NA, Liver, HepG2
RadioS↑, TumVol↓, Bcl-2↓, NF-kB↓, VCAM-1↓, ERK↓, DNAdam↑, TumCCA↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death ⓘ

Bcl-2↓, 1,  

DNA Damage & Repair ⓘ

DNAdam↑, 1,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

ERK↓, 1,  

Migration ⓘ

VCAM-1↓, 1,  

Immune & Inflammatory Signaling ⓘ

NF-kB↓, 1,  

Drug Metabolism & Resistance ⓘ

RadioS↑, 1,  

Functional Outcomes ⓘ

TumVol↓, 1,  
Total Targets: 8

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: RadioS, RadioSensitizer
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:170  Target#:1107  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page